SPRB

Conviction 28HealthcareScan · Thu, Jun 25, 2026

Dragonfly doji

SPRB$52.80+1.78%

ResistanceSupportVol 14

Vol MA14 73.33K

Mar 26Apr 14May 1May 19Jun 8Jun 25

SPRUCE BIOSCIENCES, INC.PHARMACEUTICAL PREPARATIONSwww.sprucebiosciences.com ↗

Price52.80

Change+1.78%

Gap+1.51%

Rel volume3.03×

Avg volume66.4K

Avg $ vol3.39M

SMA 2050.46

SMA 5054.21

SMA 20072.37

Price vs 50-2.61%

Price vs 200-27.04%

MA stackbearish

50/200 cross—

Supertrenddown · 59.32

RSI (14)52

MACD hist0.70

MACD cross—

Stoch %K / %D67 / 61

ADX (14)15

+DI / −DI19 / 18

RSI divergence—

MACD divergence—

ATR %+7.02%

ADR %7.14%

52w high182.60

52w low0.0786

From 52w high-71.09%

Above 52w low+67069.21%

New 52w highNo

SqueezeOn · 14d

Bollinger width15.62%

%B0.80

Donchian pos66.66%

Donchian high55.95

Donchian low46.49

AVWAP (52w high)107.13

vs AVWAP high-50.72%

AVWAP (52w low)82.89

vs AVWAP low-36.31%

OBV trendUp

Chaikin MF (20)0.09

Today vs 20d3.03×

Avg vol (14d)73.33K

Avg vol (20d)66.4K

Avg $ vol (20d)3.39M

Market cap145.31M

RS 3m (vs SPY)-31.66%

RS 6m (vs SPY)-41.86%

RS line new highNo

Trend template2/8

Technical rank27.8

1 week+8.28%

1 month+1.90%

3 months-24.55%

6 months-36.25%

1 year+13168.41%

YTD-41.79%

P/E-3.73

P/B4.19

P/S—

P/FCF-4.36

EPS-50.83

Div yield—

ROE-112.46%

ROA-69.38%

Debt/Eq0.19

Current4.67

EV/EBITDA-2.68

Gross margin—

Net margin—

Rev growth-100.00%

EPS growth26.53%

Price target—

Target upside—

Analyst rating—

Institutional—

Ent. value97.69M

Revenue0

Net income-12.27M

Gross profit—

Free cash flow-33.33M

IndustryPHARMACEUTICAL PREPARATIONS

ExchangeNasdaq

Shares out2.75M

Employees8

ListedFri, Oct 9, 2020

Free float722.82K

Float %67.5%

Short interest241.93K

Days to cover4.2d

Short volume63.5%

Squeeze score92 / 100

Next earnings—

EPS forecast—

Last EPS vs est−$8.94 vs −$7.32

Last surprise-22.1% miss

Setup gradeD

Conviction28 / 100

Pattern quality—

Tech rank27.8 / 100

Group rank50 / 100

Status lane—

Setup direction—

Pattern family

Resistance—

Support—

Days since event—

Candle confirmDragonfly doji

News sentiment—

Financials as of Tue, Mar 31, 2026 · quarterly.

Congress activity

Disclosed STOCK Act trades in SPRB

All disclosures →

No recent disclosed trades by Congress in SPRB. STOCK Act filings can lag the trade by up to 45 days.

Insider activity

SEC Form 4 transactions in SPRB · 5 buys

Insider	Side	Shares	Value	Traded	Filed
Walbert Keli Director · Stock Option (Right to Buy) · 2026-05-21	Grant	1.7K	$0	2026-05-21	2026-05-26
SIMPSON CAMILLA V Director · Stock Option (Right to Buy) · 2026-05-21	Grant	1.7K	$0	2026-05-21	2026-05-26
GREY MICHAEL G Executive Chairman · Stock Option (Right to Buy) · 2026-05-21	Grant	1.7K	$0	2026-05-21	2026-05-26
SPIEGELMAN DANIEL K Director · Stock Option (Right to Buy) · 2026-05-21	Grant	1.7K	$0	2026-05-21	2026-05-26
Barretto-Ko Percival Director · Stock Option (Right to Buy) · 2026-05-21	Grant	1.7K	$0	2026-05-21	2026-05-26

SEC filings

EDGAR filings in SPRB

EDGAR →

No recent SEC filings on file for SPRB.

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 7 days, cancel in one click.

Start free — 7-day full access →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.